Scientific papers (Please click on the paper titles to download them)
- Mendiratta S, Ahmed Ali AA, Hejazi S, Gates I. Dual Stimuli-Responsive Pickering Emulsions from Novel Magnetic Hydroxyapatite Nanoparticles and Their Characterization Using a Microfluidic Platform. Langmuir, 2021.
- Ahmed Ali AA, Lee YR, Wu A, Yadav V, Yu DS, Huang HS. Structure-based strategies for synthesis, lead optimization and biological evaluation of N-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as potential multi-target anticancer agents. Arab J Chem, 2021
- Ahmed Ali AA *, Shahror RA, Chen KY. Efficient Labeling Of Mesenchymal Stem Cells For High Sensitivity Long-Term MRI Monitoring In Live Mice Brains. Int J Nanomed, 2020.
- Mendiratta S, Ahmed Ali AA *. Recent Advances in Functionalized Mesoporous Silica Frameworks for Efficient Desulfurization of Fuels. Nanomaterials, 2020.
- Mendiratta S, Hussein M, Nasser HA, Ahmed Ali AA *. Multidisciplinary Role of Mesoporous Silica Nanoparticles in Brain Regeneration and Cancers: From Crossing the Blood–Brain Barrier to Treatment. Part Part Syst Charact, 2019.
- Shahror RA, Ahmed Ali AA, Wu CC, Chiang YH, Chen KY. Enhanced Homing of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 to Injury Site in a Mouse Model of Traumatic Brain Injury. Int J Mol Sci, 2019.
- Hsu FT, Liu HS, Ahmed Ali AA, Tsai PH, Kao YC, Lu CF, Huang HS, Chen CY. Assessing the selective therapeutic efficacy of superparamagnetic erlotinib nanoparticles in lung cancer by using quantitative magnetic resonance imaging and a nuclear factor kappa-B reporter gene system . Nanomedicine, 2018.
- Fann LY, Chen Y, Chu DC, Weng SJ, Chu HC, Wu AT, Lee JF, Ahmed Ali AA, Chen TC, Huang HS, Ma KH. Identification and preclinical evaluation of the small molecule, NSC745887, for treating glioblastomas via suppressing DcR3-associated signaling pathways. Oncotarget, 2017.
- Chen HL, Hsu FT, Kao YJ, Liu HS, Huang WZ, Lu CF, Tsai PH, Ahmed Ali AA, Lee GA, Chen RJ, Chen CY. Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro. J Nanobiotechnology, 2017.
- Ahmed Ali AA, Hsu FT, Hsieh CL, Shiau CY, Chiang CH, Wei ZH, Chen CY, Huang HS. Erlotinib-Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRI. Scientific Reports, 2016.
- Ahmed Ali AA, Lee YR, Chen TC, Chen CL, Lee CC, Shiau CY, Chiang CH, Huang HS. Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination. PLOS ONE, 2016.
- Chen CL; Lee CC; Liu FL; Chen TC; Ahmed Ali AA; Chang DM; Huang HS. Design, synthesis and SARs of novel salicylanilides as potent inhibitors of RANKL-induced osteoclastogenesis and bone resorption. Eur J Med Chem, 2016.
- Lee CC; Liu FL; Chen CL; Chen TC; Liu FC; Ahmed Ali AA; Chang DM; Huang HS. Novel inhibitors of RANKL-induced osteoclastogenesis: Deign, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones. Bioorg Med Chem, 2015.
- Chen CL, Chen TC, Lee CC, Shih LC, Lin CY, Hsieh YY, Ahmed Ali AA, Huang HS. Synthesis and evaluation of new 3-substituted-4-chloro-thioxanthone derivatives as potent anti-breast cancer agents. Arab J Chem, 2015.
- Lee YR; Chen, TC; Lee CC; Chen CL; Ahmed Ali AA; Tikhomirov A; Guh JH; Yu DS; Huang HS. Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-diones as promising scaffold of antitumor agents. Eur J Med Chem, 2015.
- Chen CL; Liu FL; Lee CC; Chen TC; Ahmed Ali AA; Sytwu HK; Chang DM; Huang HS. Modified salicylanilide and 3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives as novel inhibitors of osteoclast differentiation and bone resorption. J Med Chem, 2014.
- Chen CL; Liu FL; Lee CC; Chen TC; Chang WW; Guh JH; Ahmed Ali AA; Chang DM; Huang HS. Ring Fusion Strategy for the Synthesis of Anthra[2,3-d]oxazole-2-thione-5,10-dione Homologues as DNA Topoisomerase Inhibitors and as Antitumor Agents. Eur J Med Chem, 2014.
Theses
- "Formulation of smart cancer-targeted theranostic nanoparticles, molecular targets identification and biological evaluation of small-molecule drugs". Thesis submitted in partial fulfillment of the requirements for the Degree of philosophy in Molecular and Cell Biology program of Academia Sinica at 2017.
- "A study of the microbial quality, preservation and safety of some ophthalmic pharmaceutical and cosmetic preparations". Thesis submitted in partial fulfillment of the requirements for the Degree of Master of Pharmaceutical Sciences in Microbiology & Immunology of Cairo University at 2010.
Patents
- Dextran magnetic iron nanoparticle, preparation method and use thereof for cancer comprising a dextran layer, a magnetic iron nanoparticle and an active drug, and useful for the treatment of cancer and for imaging. Inventors: HUANG HSU-SHAN; CHEN CHENG-YU; ALI AHMED ATEF AHMED; HSU FEI-TING. Bibliographic data: TW201821061 (A) ― 2018-06-16
- 葡聚糖磁性铁奈米颗粒、制备及在治疗癌症与造影的用途. Inventors:CHEN CHENG-YU; ALI AHMED ATEF AHMED; HSU FEI-TING; HUANG HSU-SHAN. Bibliographic data: WO2018098705A1